6533b861fe1ef96bd12c535c

RESEARCH PRODUCT

“OXXEL (oxaliplatin plus Xeloda) vs OXAFAFU (oxaliplatin plus folinic acid-modulated 5-fluorouracil i.v. bolus) every 2 weeks in metastatic colorectal carcinoma (MCC): preliminary safety and activity analysis of a Southern Italy Cooperative Oncology Group (SICOG) phase III trial”

Comella PFilippelli GMassidda BPutzu CNatale DMaiorino LCondemi GLeo S. Gambardella A.Sergio Palmeri

subject

http://hdl.handle.net/10447/11407